Celestica Announces New Normal Course Issuer Bid
Celestica Inc. (NYSE: CLS) (TSX: CLS), a prominent provider of advanced manufacturing and supply chain solutions, has made a significant announcement regarding its share repurchase strategy. The company recently declared the termination of its existing normal course issuer bid in favor of a refreshed approach that aligns with its current operational and financial goals.
Details of the Normal Course Issuer Bid
The previous bid, which started in December 2023, allowed Celestica to buy back a portion of its shares up until December 2024. However, this will now conclude early, paving the way for the new normal course issuer bid. Under the existing terms, by mid-October 2024, Celestica repurchased nearly 2.9 million shares at an average price of approximately US$43.28 each.
Understanding the New Bid
The newly accepted bid allows Celestica to repurchase up to 8.6 million common shares over the period starting November 1, 2024, until October 31, 2025. This represents about 10% of the company’s public float, thereby directly facilitating stock ownership among existing shareholders.
Regulatory Framework and Limitations
Celestica will adhere to Toronto Stock Exchange (TSX) regulations, restricting daily purchases based on average trading volume. During the last measured period, the average daily trading volume was recorded at approximately 643,696 shares. As such, the daily buyback under the new bid will cap at around 160,924 shares, ensuring compliance with trading regulations and transparent practices.
Rationale Behind the Share Repurchase
The decision to initiate this new bid is rooted in the company’s commitment to maximizing shareholder value. Celestica’s management believes that investing in its own shares is a prudent use of capital, particularly in light of the current market dynamics.
Funding the New Bid
Funding for the shares repurchased under the new bid will come from Celestica's cash resources as well as amounts drawn from its credit facilities. This strategic decision reflects a robust fiscal strategy aimed at not only bolstering investor confidence but also ensuring long-term growth.
Current Shareholder Information
As of late October 2024, Celestica has a total of approximately 116.3 million issued and outstanding common shares. The public float has been reported to be around 115.3 million shares, indicating the available shares accessible for trading within the market.
Insights About Celestica
Celestica is dedicated to fostering innovation and providing exceptional service across various sectors, including Aerospace and Defense, Communications, and HealthTech. The company's strength lies in its customer-centric approach and ability to devise solutions for complex challenges across the product development spectrum, from conception to production and after-market support.
Frequently Asked Questions
What is the Normal Course Issuer Bid?
A Normal Course Issuer Bid is a program that allows a company to repurchase its own shares to enhance shareholder value, offering potential benefits through increased share price and improved capital structure.
Why did Celestica terminate its previous bid?
Celestica decided to terminate the previous issuer bid to implement a new approach that better suits its current strategic and financial objectives.
How many shares can Celestica repurchase in the new bid?
Under the new bid, Celestica is permitted to repurchase up to 8.6 million common shares, which equates to about 10% of its public float.
What influences the number of shares Celestica can buy daily?
The daily repurchase limit is influenced by the average daily trading volume, which is confined by TSX regulations to ensure fair trading practices.
How will the repurchased shares affect existing shareholders?
Repurchasing shares can potentially increase the value of remaining shares by reducing the overall supply, thereby improving the shareholders' equity in the company.
